Physician profile
Edwin Grimsley
NPI 1952486920
$697.76
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $96.05 · 2021: $180 · 2022: $249 · 2023: $35.40 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $162.74 | 2020-2024 | Rezzayo, Orbactiv, Kimyrsa |
| Janssen Pharmaceuticals, INC | $79.25 | 2021-2024 | Xarelto |
| Aurinia Pharma U.S., INC. | $73.21 | 2022-2024 | Lupkynis |
| Alexion Pharmaceuticals, INC. | $71.24 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $63.76 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $58.68 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $50.26 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $48.50 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $23.88 | 2024 | Xerava |
| Novo Nordisk INC | $19.20 | 2023 | Ozempic, Rybelsus |
| Pfizer INC. | $16.20 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.50 | 2020 | |
| Intuitive Surgical, INC. | $15.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Grimsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.